USD 28.9
(3.73%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 2.65 Billion USD | 209.71% |
2022 | -2.42 Billion USD | -288.55% |
2021 | 1.28 Billion USD | 16.52% |
2020 | 1.1 Billion USD | 10.09% |
2019 | 1 Billion USD | -38.36% |
2018 | 1.62 Billion USD | 126.5% |
2017 | 717 Million USD | -85.56% |
2016 | 4.96 Billion USD | 412.91% |
2015 | 968 Million USD | -61.23% |
2014 | 2.49 Billion USD | 24.11% |
2013 | 2.01 Billion USD | -13.5% |
2012 | 2.32 Billion USD | 4.59% |
2011 | 2.22 Billion USD | 56.62% |
2010 | 1.42 Billion USD | -35.6% |
2009 | 2.2 Billion USD | 9.48% |
2008 | 2.01 Billion USD | 17.98% |
2007 | 1.7 Billion USD | 22.28% |
2006 | 1.39 Billion USD | 46.03% |
2005 | 956 Million USD | 146.39% |
2004 | 388 Million USD | -55.96% |
2003 | 881 Million USD | 13.24% |
2002 | 778 Million USD | 27.12% |
2001 | 612 Million USD | -17.3% |
2000 | 740 Million USD | -7.15% |
1999 | 797 Million USD | 153.02% |
1998 | 315 Million USD | 5.0% |
1997 | 300 Million USD | -55.16% |
1996 | 669 Million USD | 3.08% |
1995 | 649 Million USD | 8.89% |
1994 | 596 Million USD | 401.01% |
1993 | -198 Million USD | -144.9% |
1992 | 441 Million USD | -25.38% |
1991 | 591 Million USD | 1377.5% |
1990 | 40 Million USD | -91.03% |
1989 | 446 Million USD | 14.95% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -314 Million USD | -948.65% |
2024 Q1 | 37 Million USD | -84.9% |
2023 Q2 | -141 Million USD | -420.45% |
2023 Q4 | 245 Million USD | -90.23% |
2023 Q3 | 2.5 Billion USD | 1878.72% |
2023 Q1 | 44 Million USD | -75.69% |
2023 FY | 2.65 Billion USD | 209.71% |
2022 Q1 | 71 Million USD | -70.17% |
2022 Q2 | 252 Million USD | 254.93% |
2022 Q4 | 181 Million USD | 106.17% |
2022 FY | -2.42 Billion USD | -288.55% |
2022 Q3 | -2.93 Billion USD | -1264.29% |
2021 Q4 | 238 Million USD | -47.11% |
2021 Q3 | 450 Million USD | 51.01% |
2021 Q2 | 298 Million USD | 0.0% |
2021 FY | 1.28 Billion USD | 16.52% |
2021 Q1 | 298 Million USD | 77.38% |
2020 Q3 | 356 Million USD | 44.72% |
2020 Q4 | 168 Million USD | -52.81% |
2020 FY | 1.1 Billion USD | 10.09% |
2020 Q2 | 246 Million USD | -25.9% |
2020 Q1 | 332 Million USD | 1543.48% |
2019 Q3 | 369 Million USD | 17.89% |
2019 Q4 | -23 Million USD | -106.23% |
2019 Q2 | 313 Million USD | -8.48% |
2019 Q1 | 342 Million USD | -1.72% |
2019 FY | 1 Billion USD | -38.36% |
2018 Q3 | 518 Million USD | 51.02% |
2018 FY | 1.62 Billion USD | 126.5% |
2018 Q4 | 348 Million USD | -32.82% |
2018 Q2 | 343 Million USD | -11.83% |
2018 Q1 | 389 Million USD | 647.89% |
2017 Q2 | 265 Million USD | -2.57% |
2017 Q3 | 251 Million USD | -5.28% |
2017 FY | 717 Million USD | -85.56% |
2017 Q4 | -71 Million USD | -128.29% |
2017 Q1 | 272 Million USD | 11.93% |
2016 Q4 | 243 Million USD | 86.92% |
2016 FY | 4.96 Billion USD | 412.91% |
2016 Q1 | 3.38 Billion USD | 1548.78% |
2016 Q2 | 1.21 Billion USD | -64.14% |
2016 Q3 | 130 Million USD | -89.27% |
2015 Q3 | 1 Million USD | -99.7% |
2015 FY | 968 Million USD | -61.23% |
2015 Q1 | 430 Million USD | -54.88% |
2015 Q2 | 332 Million USD | -22.79% |
2015 Q4 | 205 Million USD | 20400.0% |
2014 Q3 | 468 Million USD | -10.0% |
2014 FY | 2.49 Billion USD | 24.11% |
2014 Q1 | 556 Million USD | 70.55% |
2014 Q4 | 953 Million USD | 103.63% |
2014 Q2 | 520 Million USD | -6.47% |
2013 Q4 | 326 Million USD | -40.07% |
2013 FY | 2.01 Billion USD | -13.5% |
2013 Q1 | 552 Million USD | 11.74% |
2013 Q2 | 590 Million USD | 6.88% |
2013 Q3 | 544 Million USD | -7.8% |
2012 FY | 2.32 Billion USD | 4.59% |
2012 Q1 | 588 Million USD | 27.0% |
2012 Q2 | 661 Million USD | 12.41% |
2012 Q3 | 583 Million USD | -11.8% |
2012 Q4 | 494 Million USD | -15.27% |
2011 FY | 2.22 Billion USD | 56.62% |
2011 Q1 | 570 Million USD | 34.75% |
2011 Q2 | 615 Million USD | 7.89% |
2011 Q3 | 576 Million USD | -6.34% |
2011 Q4 | 463 Million USD | -19.62% |
2010 Q2 | 535 Million USD | 1.9% |
2010 Q4 | 423 Million USD | -19.43% |
2010 Q1 | 525 Million USD | -8.22% |
2010 FY | 1.42 Billion USD | -35.6% |
2010 Q3 | 525 Million USD | -1.87% |
2009 FY | 2.2 Billion USD | 9.48% |
2009 Q3 | 530 Million USD | -9.71% |
2009 Q2 | 587 Million USD | 13.76% |
2009 Q1 | 516 Million USD | -9.31% |
2009 Q4 | 572 Million USD | 7.92% |
2008 FY | 2.01 Billion USD | 17.98% |
2008 Q2 | 544 Million USD | 26.81% |
2008 Q4 | 569 Million USD | 20.55% |
2008 Q3 | 472 Million USD | -13.24% |
2008 Q1 | 429 Million USD | -10.25% |
2007 FY | 1.7 Billion USD | 22.28% |
2007 Q4 | 478 Million USD | 21.01% |
2007 Q3 | 395 Million USD | -8.35% |
2007 Q2 | 431 Million USD | 6.95% |
2007 Q1 | 403 Million USD | -6.5% |
2006 Q2 | 309 Million USD | 9.57% |
2006 Q1 | 282 Million USD | -3.42% |
2006 FY | 1.39 Billion USD | 46.03% |
2006 Q4 | 431 Million USD | 15.24% |
2006 Q3 | 374 Million USD | 21.04% |
2005 Q3 | 116 Million USD | -63.98% |
2005 FY | 956 Million USD | 146.39% |
2005 Q2 | 322 Million USD | 42.48% |
2005 Q1 | 226 Million USD | 113.21% |
2005 Q4 | 292 Million USD | 151.72% |
2004 Q3 | 276 Million USD | 262.35% |
2004 Q1 | 178 Million USD | -52.02% |
2004 Q4 | 106 Million USD | -61.59% |
2004 FY | 388 Million USD | -55.96% |
2004 Q2 | -170 Million USD | -195.51% |
2003 Q2 | 35 Million USD | -83.8% |
2003 Q4 | 371 Million USD | 44.92% |
2003 Q3 | 256 Million USD | 631.43% |
2003 Q1 | 216 Million USD | 2300.0% |
2003 FY | 881 Million USD | 13.24% |
2002 Q1 | 253 Million USD | 437.33% |
2002 Q4 | 9 Million USD | -97.15% |
2002 Q2 | 200 Million USD | -20.95% |
2002 Q3 | 316 Million USD | 58.0% |
2002 FY | 778 Million USD | 27.12% |
2001 Q3 | 272 Million USD | 7.51% |
2001 Q2 | 253 Million USD | 56.17% |
2001 FY | 612 Million USD | -17.3% |
2001 Q1 | 162 Million USD | -40.0% |
2001 Q4 | -75 Million USD | -127.57% |
2000 Q2 | 48 Million USD | -74.87% |
2000 Q4 | 270 Million USD | 16.88% |
2000 FY | 740 Million USD | -7.15% |
2000 Q3 | 231 Million USD | 381.25% |
2000 Q1 | 191 Million USD | -16.59% |
1999 FY | 797 Million USD | 153.02% |
1999 Q1 | 151 Million USD | -28.77% |
1999 Q2 | 207 Million USD | 37.09% |
1999 Q3 | 210 Million USD | 1.45% |
1999 Q4 | 229 Million USD | 9.05% |
1998 Q1 | 164 Million USD | -9.89% |
1998 FY | 315 Million USD | 5.0% |
1998 Q4 | 212 Million USD | 270.97% |
1998 Q2 | 63 Million USD | -61.59% |
1998 Q3 | -124 Million USD | -296.83% |
1997 Q4 | 182 Million USD | 14.47% |
1997 FY | 300 Million USD | -55.16% |
1997 Q1 | -203 Million USD | -228.48% |
1997 Q2 | 162 Million USD | 179.8% |
1997 Q3 | 159 Million USD | -1.85% |
1996 Q4 | 158 Million USD | -10.73% |
1996 Q3 | 177 Million USD | 0.57% |
1996 Q2 | 176 Million USD | 11.39% |
1996 Q1 | 158 Million USD | -10.23% |
1996 FY | 669 Million USD | 3.08% |
1995 Q2 | 165 Million USD | 13.79% |
1995 Q1 | 145 Million USD | -15.7% |
1995 FY | 649 Million USD | 8.89% |
1995 Q4 | 176 Million USD | 7.98% |
1995 Q3 | 163 Million USD | -1.21% |
1994 Q4 | 172 Million USD | 15.44% |
1994 Q2 | 144 Million USD | 9.92% |
1994 Q3 | 149 Million USD | 3.47% |
1994 FY | 596 Million USD | 401.01% |
1994 Q1 | 131 Million USD | 121.72% |
1993 Q3 | 135 Million USD | 2.27% |
1993 Q2 | 132 Million USD | -4.35% |
1993 Q4 | -603 Million USD | -546.67% |
1993 FY | -198 Million USD | -144.9% |
1993 Q1 | 138 Million USD | 1280.0% |
1992 Q4 | 10 Million USD | -94.22% |
1992 Q1 | 126 Million USD | -29.61% |
1992 FY | 441 Million USD | -25.38% |
1992 Q3 | 173 Million USD | 36.22% |
1992 Q2 | 127 Million USD | 0.79% |
1991 Q1 | 104 Million USD | -39.53% |
1991 Q2 | 135 Million USD | 29.81% |
1991 Q3 | 150 Million USD | 11.11% |
1991 Q4 | 179 Million USD | 19.33% |
1991 FY | 591 Million USD | 1377.5% |
1990 Q4 | 172 Million USD | 43.33% |
1990 Q3 | 120 Million USD | 27.66% |
1990 Q1 | -383 Million USD | -408.87% |
1990 Q2 | 94 Million USD | 124.54% |
1990 FY | 40 Million USD | -91.03% |
1989 Q1 | 85 Million USD | 0.0% |
1989 Q3 | 87 Million USD | -1.14% |
1989 Q2 | 88 Million USD | 3.53% |
1989 Q4 | 124 Million USD | 42.53% |
1989 FY | 446 Million USD | 14.95% |
Name | Net Income | Net Income Difference |
---|---|---|
Phreesia, Inc. | -136.88 Million USD | 2040.315% |
Accuray Incorporated | -15.54 Million USD | 17185.88% |
Align Technology, Inc. | 445.05 Million USD | -496.783% |
Elevance Health Inc. | 5.98 Billion USD | 55.637% |
AxoGen, Inc. | -21.71 Million USD | 12330.613% |
Boston Scientific Corporation | 1.59 Billion USD | -66.729% |
CVS Health Corporation | 8.34 Billion USD | 68.169% |
Cardinal Health, Inc. | 852 Million USD | -211.737% |
Centene Corporation | 2.7 Billion USD | 1.702% |
DaVita Inc. | 691.53 Million USD | -284.073% |
HCA Healthcare, Inc. | 5.24 Billion USD | 49.332% |
Hologic, Inc. | 789.5 Million USD | -236.415% |
Humana Inc. | 2.48 Billion USD | -6.71% |
IDEXX Laboratories, Inc. | 845.04 Million USD | -214.304% |
Laboratory Corporation of America Holdings | 418 Million USD | -535.407% |
Masimo Corporation | 81.5 Million USD | -3158.896% |
McKesson Corporation | 3 Billion USD | 11.526% |
Patterson Companies, Inc. | 185.93 Million USD | -1328.487% |
Quest Diagnostics Incorporated | 854 Million USD | -211.007% |
ResMed Inc. | 1.02 Billion USD | -160.15% |
Henry Schein, Inc. | 416 Million USD | -538.462% |
Teladoc Health, Inc. | -220.36 Million USD | 1305.257% |
Universal Health Services, Inc. | 717.79 Million USD | -270.022% |
Veeva Systems Inc. | 525.7 Million USD | -405.226% |
Becton, Dickinson and Company | 1.48 Billion USD | -78.976% |
Intuitive Surgical, Inc. | 1.79 Billion USD | -47.72% |
Danaher Corporation | 4.2 Billion USD | 36.762% |
Stryker Corporation | 3.16 Billion USD | 16.082% |
Medtronic plc | 3.67 Billion USD | 27.748% |